Michel Duval
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma (NCT07518654) | Michel Duval | 2026-05-01 |
Track Michel Duval automatically
Every clearance here is in the API, with alerts when new ones post.